XML 75 R28.htm IDEA: XBRL DOCUMENT
v3.25.0.1

Description of the Business (Details) - USD ($) $ in Millions | 1 Months Ended |
--- | --- | ---
Jul. 31, 2024 | Oct. 28, 2024
Restructuring Cost and Reserve [Line Items] |  |
Percentage of reduction in workforce under corporate restructuring | 80.00% |
Net cash at closing of the merger |  | $ 1.0
Private Placement |  |
Restructuring Cost and Reserve [Line Items] |  |
Aggregate purchase price |  | $ 200.0
Prior to closing of private placement | Crescent Biopharma, Inc. |  |
Restructuring Cost and Reserve [Line Items] |  |
Parent ownership (as percentage) |  | 86.20%
Prior to closing of private placement | GlycoMimetics, Inc. |  |
Restructuring Cost and Reserve [Line Items] |  |
Noncontrolling ownership (as percentage) |  | 13.80%
Post the Closing of Private Placement [Member] | Crescent Biopharma, Inc. |  |
Restructuring Cost and Reserve [Line Items] |  |
Parent ownership (as percentage) |  | 96.90%
Post the Closing of Private Placement [Member] | GlycoMimetics, Inc. |  |
Restructuring Cost and Reserve [Line Items] |  |
Noncontrolling ownership (as percentage) |  | 3.10%

X
- Definition The maximum net cash of the company at the closing of the merger for the determination of the exchange ratio of shares as per the agreement. + References No definition available. + Details
Name: | glyc_MergerAgreementExchangeRatioDeterminationMaximumNetCashAtClosing
Namespace Prefix: | glyc_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition The aggregate value of shares and warrants to be issued by the entity as per the stock transaction. + References No definition available. + Details
Name: | glyc_SaleOfStockAggregatePurchasePrice
Namespace Prefix: | glyc_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition The equity interest of noncontrolling shareholders, partners or other equity holders in consolidated entity. + References No definition available. + Details
Name: | us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition The parent entity's interest in net assets of the subsidiary, expressed as a percentage. + References No definition available. + Details
Name: | us-gaap_MinorityInterestOwnershipPercentageByParent
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition The number of positions eliminated during the period as a percentage of total positions eliminated during the period in connection with the restructuring plan(s). + References No definition available. + Details
Name: | us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 420 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SAB Topic 5.P.4.d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479823/420-10-S99-2 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 420 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SAB Topic 5.P.4.b.1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479823/420-10-S99-2 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 420 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SAB Topic 5.P.4.b.2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479823/420-10-S99-2 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 420 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482017/420-10-50-1 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 420 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (b)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482017/420-10-50-1 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 420 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (b)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482017/420-10-50-1 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 420 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482017/420-10-50-1 + Details
Name: | us-gaap_RestructuringCostAndReserveLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_StatementScenarioAxis=glyc_PriorToClosingOfPrivatePlacementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_OwnershipAxis=glyc_CrescentBiopharmaIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_OwnershipAxis=glyc_GlycoMimeticsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_StatementScenarioAxis=glyc_PostClosingOfPrivatePlacementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |